Gilead has reported results for a once-yearly intramuscular injection that show blood concentrations of lenacapavir exceeded ...

Patients are grappling with a shortage of HIV drugs even as an emergency consignment worth $34 million (Sh4.4bn) has been stored at a warehouse in Nairobi since last year awaiting distribution.The ...

It was later discovered that one of the donors was HIV positive, leading to her infection..HIV, AIDS, Cancer patient, RCC, Kerala High Court ...

The Infected Blood Inquiry said it will publish a further report looking at the adequacy of the Government’s approach to ...

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced positive findings from the company’s EMBRACE phase IIb study.

Researchers from the HIV Prevention Trials Network (HPTN) have presented results from the HPTN 094 ("INTEGRA") study at the ...

To learn more, please visit www.reprievetrial.org.

A team of pharmaceutical researchers at biopharma company Gilead Sciences has announced that a reformulation of its HIV ...